Here's the live share price of Innova Captab along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Innova Captab has gained 9.43% CAGR. Over the past year, the corresponding return has been 6.16%.
Innova Captab’s current P/E of 37.73x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Innova Captab | -0.52 | -5.12 | -0.16 | 1.22 | 6.16 | 16.21 | 9.43 |
Sun Pharmaceutical Industries | 2.44 | 1.01 | 0.08 | -5.70 | -10.03 | 23.54 | 25.80 |
Divi's Laboratories | 1.48 | -1.04 | -6.66 | 5.61 | 11.59 | 19.02 | 12.76 |
Cipla | 1.12 | 0.89 | 5.34 | 4.62 | -4.45 | 15.11 | 14.36 |
Torrent Pharmaceuticals | -0.61 | -2.60 | 10.27 | 13.47 | 5.88 | 33.98 | 19.88 |
Dr. Reddy's Laboratories | 1.47 | 4.64 | 0.74 | 13.55 | 0.67 | 17.28 | 4.42 |
Mankind Pharma | 1.47 | 6.68 | 11.93 | 22.76 | 9.94 | 22.77 | 13.10 |
Zydus Lifesciences | 0.42 | 6.22 | 9.41 | 16.03 | -2.91 | 42.82 | 20.69 |
Lupin | 3.09 | 4.09 | 4.93 | 0.72 | -7.84 | 47.29 | 13.56 |
Abbott India | 0.01 | -5.05 | -1.67 | 3.97 | 11.46 | 21.23 | 13.41 |
Aurobindo Pharma | 1.70 | 3.53 | 1.94 | -0.76 | -26.66 | 29.49 | 6.38 |
Alkem Laboratories | 1.53 | 2.45 | 14.06 | 13.83 | -10.04 | 19.08 | 13.91 |
Glenmark Pharmaceuticals | -0.70 | 6.98 | 27.23 | 44.88 | 28.39 | 78.62 | 32.94 |
Laurus Labs | 3.14 | 6.66 | 39.13 | 57.29 | 90.35 | 22.06 | 25.31 |
Biocon | 1.24 | 1.14 | 7.66 | 9.58 | 1.29 | 8.29 | -4.09 |
Anthem Biosciences | 4.22 | 6.77 | 17.06 | 17.06 | 17.06 | 5.39 | 3.20 |
GlaxoSmithKline Pharmaceuticals | -3.99 | -1.44 | -16.30 | -1.53 | -1.64 | 24.90 | 10.11 |
Cohance Lifesciences | -8.13 | 1.69 | -9.19 | -19.32 | -20.15 | 25.73 | 18.74 |
Ipca Laboratories | 2.50 | -2.87 | -1.28 | -0.09 | -6.88 | 16.19 | 4.36 |
Gland Pharma | 2.66 | 2.34 | 16.40 | 27.61 | 9.52 | -3.50 | 2.08 |
Over the last one year, Innova Captab has gained 6.16% compared to peers like Sun Pharmaceutical Industries (-10.03%), Divi's Laboratories (11.59%), Cipla (-4.45%). From a 5 year perspective, Innova Captab has underperformed peers relative to Sun Pharmaceutical Industries (25.80%) and Divi's Laboratories (12.76%).
Day | SMA | EMA |
---|---|---|
5 | 862.78 | 864.52 |
10 | 878.88 | 874.97 |
20 | 894.94 | 886.43 |
50 | 897.18 | 891.78 |
100 | 888.81 | 889.61 |
200 | 916.62 | 862.43 |
In the latest quarter, Innova Captab remained same as its previous close in promoter holding, while DII stake decreased to 19.67%, FII holding fell to 0.23%, and public shareholding moved up to 29.20% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
---|---|---|---|
Kotak Multicap Fund | 17,88,920 | 0.84 | 161.37 |
Canara Robeco Small Cap Fund | 16,29,936 | 1.17 | 147.03 |
Invesco India Mid Cap Fund | 8,72,463 | 0.98 | 78.7 |
Invesco India Smallcap Fund | 6,30,001 | 0.74 | 56.83 |
Bandhan Small Cap Fund | 2,61,881 | 0.16 | 23.62 |
Canara Robeco Value Fund | 1,64,500 | 1.17 | 14.84 |
PGIM India Small Cap Fund | 46,227 | 0.27 | 4.17 |
Motilal Oswal BSE Healthcare ETF | 370 | 0.11 | 0.03 |
Date Time | Announcement |
---|---|
Sep 17, 2025, 12:14 AM IST | Innova Captab - Pursuant To Regulation 30 Read With Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requir |
Aug 22, 2025, 12:14 AM IST | Innova Captab - Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure |
Aug 21, 2025, 2:41 AM IST | Innova Captab - Pursuant To The Regulation 30 (Read With Part A Of Schedule III) And Other Applicable Provisions Of SEBI (Lis |
Aug 13, 2025, 11:43 PM IST | Innova Captab - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
Aug 08, 2025, 11:16 PM IST | Innova Captab - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
Innova Captab Ltd. is a Public Limited Listed company incorporated on 03/01/2005 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24246MH2005PLC150371 and registration number is 150371. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 958.06 Cr. and Equity Capital is Rs. 57.23 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Innova Captab is ₹855.65 as on Sep 18, 2025.
The Innova Captab is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Innova Captab is ₹4,896.45 Cr as on Sep 18, 2025.
Today’s highest and lowest price of Innova Captab are ₹868.15 and ₹850.00.
The 52-week high/low is the highest and lowest price at which Innova Captab stock has traded in the past 52-week or nearly a year. The 52-week high of Innova Captab is ₹1,259.00 and 52-week low of Innova Captab is ₹663.55 as on Sep 18, 2025.
The Innova Captab has shown returns of -0.75% over the past day, -5.12% for the past month, -0.16% over 3 months, 6.16% over 1 year, 16.21% across 3 years, and 9.43% over 5 years.
P/E ratio of and PB ratio of Innova Captab are 37.73 and 5.47 on Sep 18, 2025. While the company gives a dividend yield of 0.00 per annum.